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ABSTRACT 
Two new conjugates of murrayafoline A with zerumbone and artemisinin 3, 11 were 
prepared by N-alkylation, in which, compound 3 was synthesized from two consecutive N-
alkylation reactions. Their cytotoxicity was evaluated on four human cancer cell lines Hep-G2, 
LU, RD and Fl. The result showed that both compounds exhibited no activity against the tested 
cell lines.  
Keywords: murrayafoline A, N-alkylation, cytotoxicity, sesquiterpene, conjugate. 
1. INTRODUCTION 
A number of natural carbazole alkaloids were recognized to exhibit potential biological 
activities such as antimicrobial [1, 2], anti-HIV [3], anticancer [4, 5, 6] activities. Among them, 
several compounds were used as drugs for treatment of cancer [7]. Especially, murrayafoline A, 
a well-known carbazole alkaloid is promising cytotoxic carbazole in the roots of G. stenocarpa 
in Vietnam. This carbazole was reported to show significant growth suppression of the human 
leukemia cell line HL-60 due to apoptosis mediated by the activation of the caspase-9/caspase-3 
pathway [7] and prevent heart diseases [8]. Recently, some of the N-substituted derivatives were 
synthesized and evaluated the anti-inflamamtory activity [9]. However, no reports on the 
synthesis and biological evaluation of conjugates between murrayfoline A and other bioactive 
compounds are available. In this respect, we report herein the synthesis and cytotoxicity 
evaluation of two new conjugates of murrayafoline A and sesquiterpenes. 
2. MATERIALS AND METHODS 
All chemicals were purchased from Sigma-Aldrich (USA). Murrayafoline A was isolated 
from rhizome of Glycosmis stenocarpa in Vietnam.  Melting points were measured in open 
capillary tubes on a Buchi 530 (Switzerland) melting point apparatus and were uncorrected. 
NMR spectra were recorded on a Bruker Advance 500M using tetramethylsilane (TMS) as 
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internal standard. Mass spectra were recorded on a FTICR MS Varian and an Agilent 1200 
Series LC-MSD 6310 Ion Trap LC/MS. 
1.1. Synthesis of conjugate 3 
2.1.1. Synthesis of 3-(1-methoxy-3-methyl-N-carbazolyl)propyl bromide 2 
Compound 2 was synthesized from murrayafoline A according to the procedure as 
described in reference [9]. 
2.1.2. Synthesis of azazerumbone 7,8 
Synthesis of zerumbone oximes 5, 6 
To a solution of zerumbone (0.3 g, 1.38 mmol) in absolute ethanol (10 mL), 
hydroxylamine hydrochloride (0.92 g, 13.8 mmol) and K2CO3 (0.96 g, 13.8 mmol) were added 
at room temperature. The mixture was stirred for overnight and the solid was filtered off and 
washed with ethanol. The filtrate was concentrated under reduced pressure to afford a white 
solid mass, which was dissolved in dichloromethane (10 ml). The organic layer was washed 
with water (3 × 10 mL) and dried over anhydrous sodium sulfate, the solvent was removed by 
rotary evaporation to give a mixture (0.25 g, 90% yield) of E- and Z- zerumbone as white solid 
which was used for next step without purification 
Synthesis of azazerrumbones 7, 8 
To a solution of zerumbone oximes 5, 6 (1.5 g, 6.43 mmol) in dry acetonitrile (20 mL), 
anhydrous zinc chloride (0.17 g, 1.28 mmol) was added. The reaction mixture was reflux under 
nitrogen streamline and the progress of the reaction was monitored on TLC using n-H:EtOAc 
3:1. After completion of the reaction, solvent was removed under reduced pressure and the 
residue was taken in dichloromethane (20 mL). The organic layer was washed with water (3 × 
20 mL), followed by brine (20 mL) and then dried over anhydrous sodium sulfate. The solvent 
was evaporated to give crude product that was chromatographed on silica gel using n-hexane : 
ethylacetate 3:1 to afford 7 (200 mg) and 8 (600 mg) 
Azazerumbone 7: Yield 39.1 % (white crystals); mp: 145-147oC;ESI-MS (m/z): 
234.1 [M + H]+;1H-NMR (500 MHz, DMSO-d6, ppm)δ 8.35 (s, 1H, H-1'), 6.13 (d, J = 15.5 
Hz, 1H, H-4'), 5.81 (d, J = 15.5 Hz, 1H, H-3'), 5.05 (t, J = 7 Hz, 1H, H-11'), 4.72 (t, J = 7 Hz, 
1H, H-7'), 2.24 (m, 2H, 2H-10'), 2.17 (m, 2H, 2H-9'), 2.12 (d, broad, J = 6.5 Hz, 2H, 2H-6'), 
1.68 (s, 3H, H-13'), 1.52 (s, 3H, H-14'), 1.05 (s, 3H, H-15'), 1.05 (s, 3H, 3H-16'). 13C-NMR (125 
MHz, DMSO-d6, ppm) δ 166.7 (C-2'), 147.5 (C-4'), 133.7 (C-8'), 130.8 (C-12'), 125.1 (C-11'), 
124.4 (C-7'), 122.6 (C-3'), 39.0 (C-9'), 38.0 (C-6'), 36.2 (C-5'), 28.5 (C-15'), 28.5 (C-16'), 24.4 
(C-10'), 16.7 (C-14'), 14.7 (C-13').  
Azazerumbone 8: Yield 9.7 % (white crystals); mp: 165-167oC;ESI-MS (m/z): 234.3 
[M + H]+;1H-NMR (500 MHz, DMSO-d6, ppm)δ 9.20 (d, J = 9.5 Hz, 1H, H-1'), 6.05 (d, d, J1 = 
10 Hz, J2 = 14.5 Hz, 1H, H-12'), 5.37 (t, J = 6.5 Hz, 1H, H-4'), 5.13 (t, J = 6 Hz, 1H, H-8'), 4.68 
(d, J = 14.5 Hz, 1H, H-7'), 2.29 (m, 2H, 2H-5'), 2.23 (t, J = 6.0 Hz, 2H, H-6'), 2.06 (d, J = 6.5 
Hz, 2H, H-9'), 1.74 (s, 3H, 3H-13'), 1.52 (s, 3H, H-14'), 1.00 (s, 3H, H-15'), 1.00 (s, 3H, H-16'). 
13C-NMR (125 MHz, DMSO-d6, ppm) δ 172.0 (C-2'), 136.0 (C-4'), 133.2 (C-7'), 128.7 (C-3'), 
127.6 (C-12'), 125.0 (C-8'), 117.3 (C-11'), 39.0 (C-6'), 38.1 (C-9'), 34.7 (C-10'), 32.2 (C-15'), 
30.2 (C-16'), 24.1 (C-5'), 14.6 (C-14'), 13.1 (C-13'). 
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2.1.3. Synthesis of conjugate 3 
A mixture of 7 (233 mg, 1 mmol), K2CO3 (0.21 g, 1.5 mmol), compound 2 (0.42 g, 1.3 
mmol) and (1-butyl)triethylammonium bromide (23.8 mg, 0.1 mmol)  in dry 
dimethylformamide (15 mL) was thoroughly stirred at room temperature for overnight and 
solvent was removed under reduced pressure. The resulting mixture was dissolved in water (20 
mL) and extracted with EtOAc (3 × 20 mL). The combined extract was dried over anhydrous 
sodium sulfate and solvent was removed under reduced pressure. Crude 3 were purified by 
column chromatography on silica gel eluting with n-hexane : ethylacetate. 
Yield 53.6 % (White powder); mp: 130-132oC; 1H-NMR (500 MHz, DMSO-d6, ppm) δ 
8.03 (d, J = 7.5 Hz, 1H, H-8), 7.50 (s, broad, 2H, H-4, H-5), 7.39 (t, J = 7.5 Hz, 1H, H-7), 7.13 
(t, J = 7.5 Hz, 1H, H-6), 6.85 (s, 1H, H-2), 6.14 (d, J = 15.5 Hz, 1H, H-4), 5.79 (d, J = 15.5 
Hz, 1H, H-3), 4.94 (m, 2H, H-7, H-11), 4.55 (m, 2H, 9-CH2-), 3.94 (s, 3H, 1-OCH3), 2.45 
(s, 3H, 3-CH3), 2.14 (s, broad, 4H, 9-CH2-CH2-CH2-), 1.83-1.98 (s, broad, 6 H, H-10, H-6, 
H-9), 1.68 (s, 3H, H-13), 1.53 (s, 6H, H-15, H-16).  13C-NMR (125 MHz, DMSO-d6, 
ppm) δ 165.3 (C-2), 147.3 (C-4), 146.1 (C-1), 140.3 (C-13), 133.8 (C-8), 133.7 (C-12), 
131.8 (C-11), 128.6 (C-3), 127.3 (C-10), 125.4 (C-7), 124.5 (C-7), 124.1 (C-12), 123.2 (C-
3), 122.2 (C-11), 120.1 (C-6), 118.6 (C-8), 112.5 (C-4), 109.2 (C-2, C-5), 55,7 (1-OCH3), 42,7 
(9-CH2-), 40.6 (1-CH2-), 38.1 (C-9), 36.0 (C-5), 28.6 (9-CH2-CH2-), 25.0 (C-10), 21.3 
(3-CH3), 15.0 (C-14), 14.7 (C-13).  HR-MS (m/z): Found 485.31675 [M+H]+, calculated for 
C32H41N2O2: 485.31625 
2.2. Synthesis of conjugate 11 
2.2.1. Synthesis of 2-(10β-dihydroartemisinoxy)ethyl bromide 10 
The intermediate 10 was synthesized from dihydroarrtemisinin and 2-bromoethanol 
according to the procedure as described in reference [10]. 
2.2.2. Synthesis of conjugate 11 
A mixture of murrayafoline A (1) (0.211 g, 1 mmol), K2CO3 (0.621 g, 4.5 mmol), 
compound 10 (1.25 g, 3 mmol) and (1-butyl)triethylammonium bromide (35.7 mg, 0.15 mmol)  
in dry dimethylformamide (15 mL) was stirred at 70oC for 48 h and solvent was removed under 
reduced pressure. The resulting mixture was dissolved in water (20 mL) and extracted with 
EtOAc (3 × 20 mL). The combined extract was dried over anhydrous sodium sulfate and solvent 
was removed under reduced pressure to afford crude 11 that was purified by column 
chromatography on silica gel eluting with n-hexane : ethylacetate 2:1. 
Yield 45.8 % (white crystals);  mp: 176 – 178 oC; 1H-NMR (500 MHz, DMSO-d6, ppm) δ 
7.99 (d, J = 7.5 Hz, 1H, H-8), 7.53 (d, J = 8 Hz, 1H, H-5), 7.49 (s, 1H, H-4), 7.37 (t, J = 8 Hz, 
1H, H-7), 7.12 (t, J = 7.5 Hz, 1H, H-6), 6.85 (s, 1H, H-2), 4.80 (m, 1H, 9-CH2a-), 4.69 (m, 1H, 
9-CH2b-) 4.59 (s, 1H, H-12), 4.54 (d, J = 3.5 Hz, 1H, H-10), 4.17 (m, 1H, 10-O-CH2a-), 
3.96 (s, 3H, 1-OCH3), 3.64 (m, 1H, 10-O -CH2b-), 2.47 (s, 3H, 3-CH3), 2.22 (m, 1H, H-9), 
2.08 (m, 1H, 4-CH2a-), 1.88 (m, 1H, 4-CH2b-), 1.66 (m, 1H, 5-CH2a-), 1.09 (m, 1H, 5-
CH2b-), 1.20 (s, 3H, 3-CH3), 1.15 (m, 1H, H-8a), 1.09 (m, 1H, 7-CH2a-), 0.59 (m, 1H, 7-
CH2b-), 1.03 (m, 1H, 8-CH2a-), 0.89 (m, 1H, 8-CH2b-), 0.89 (m, 1H, H-5a), 0.79 (d, J = 
6Hz, 3H, 6-CH3), 0.59 (m, 1H, H-6) . 13C-NMR (125 MHz, DMSO-d6, ppm) δ 147.0 (C-1), 
141.7 (C-8), 129.2 (C-3), 128.4 (C-10), 125.7 (C-7), 125.1 (C-12), 123.0 (C-11), 120.3 (C-6), 
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119.0 (C-8), 113.0 (C-4), 110.4 (C-2), 110.0 (C-5), 103.6 (C-3), 101.3 (C-10), 87.3 (C-
12), 80.8 (C-12a), 66.9 (10-O-CH2-), 56.4 ('-OCH3), 52.6 (C-5a), 44.9 (C-8a), 44.3 (9-
CH2-), 36.9 (C-6), 36.7 (C-4), 34.7 (C-7), 30.9 (C-9), 26.2 (C-15), 24.7 (C-5), 23.9 
(C-8), 21.8 (3-CH3), 20.4 (C-14), 12.8 (C-13). HR-MS (m/z): 522.28550 [M+H]+, 
calculated for C31H40NO6: 522.28502 
2.3. In vitro anticancer assay 
The in vitro evaluation of cytotoxicity was undertaken at Institute of Natural Products 
Chemistry (VAST) according to the protocol of Likhitwitayawid [10]. The determination of 
IC50 was carried out using four human cancer cell lines: HepG2, RD, LU-1 and FL with 
ellipticine was used as a positive control. The IC50 values were determined from dose-dependent 
curve plotted from five different concentration regimens (0 - 20 µM).  
3. RESULT AND DISCUSSION 
The aim of our synthesis was to introduce a murrayafoline A moiety connected to 
sesquiterpenes, artemisinin and zerumbone by 1,3-propane or 1,2-ethane bridges to form the 
conjugatates 3, 11 and evaluate their cytotoxicity. The synthesis of new conjugates 3 and 11 was 
outlined in schemes 1, 2. For the synthesis of conjugates 3, on the one hand, 1-bromo-3-propyl 
substituent was first introduced into the position N-9 of murrayafoline A by N-alkylation 
reaction of 1 with 1,3-dibromopropane in THF in the presence of strong base NaH as catalyst to 
give the key intermediate 2 in 83.0 %  yield  and by-product 3 in 10 % [10] (scheme 1).  On the 
other hand, azazerumbone 7 was also prepared from zerumbone by a procedure in two steps. 
Firstly, zerumbone was condensed with hydroxylamine hydrochloride in ethanol with potasium 
carbonate as catalyst to create zerumbone oximes 5 and 6 with E- and Z-configuration in 90 % 
yield. In the next step, Beckmann rearrangement of 5 and 6 was conducted in the presence of 
anhydrous zinc chloride in acetonitrile to afford azazerumbone 7 and 8 in 39.1 and 9.7 % yields, 
respectively. The confirmed structures of 7 and 8 agreed with 1H-, 13C-NMR and MS data. 
Finally, conjugate 3 was successfully synthesized in 53.6 % yield by N-alkylation of 7 with 2 
using 10 % equivalent of transfer catalyst (1-butyl)triethylammonium bromide. 
 
Scheme 1. Preparation of conjugate 3. 
Reagents and conditions: (i) HO-NH2.HCl,EtOH, rt, 12 h, 90 %; (ii) ZnCl2, CH3CN, Reflux, 6 h, 39.1 % 
and 9.7 %; (iii) 1,3-Dibromopropane, NaH, THF, 72 h, 83 % (2) and 11 % (2a); (iv) 2, K2CO3, 
transfercatalyst 10 %, DMF, overnight, 53.6 %. 
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For the synthesis of conjugate 11, derivative 10 was prepared from dihydroartemisinin by 
etherification with 2-bromoethanol using BF3.Et2O in CH2Cl2 to give intermediate 10 in 46 % 
yield. This agent was used for N-alkylation of murrayafoline A in DMF in the presence of 
transfer catalyst (1-butyl)triethylammonium bromide at 70oC for 48 h to obtain the target 
compound 11 in 45.8 % yield (Scheme 2). 
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Scheme 2. Preparation of conjugate 11. 
Reagents and conditions: (i) 2-bromoethanol, BF3.Et2O, CH2Cl2, 0 oC–rt, 46 %;  
(ii) Murrayafoline A,K2CO3, transfercatalyst 10 %, DMF, 70 oC,48h, 45.8 %. 
1H-NMR spectra of 11 indicated the presence of two components murrayafoline A and 
artemisinin. The aromatic protons of murrayafoline A appeared in the range with δ values from 
6.90 – 8.11 ppm and the protons of artemisinin was found ranging from 0.53-4.92 ppm. 
Especially, the signals of carbon at 83 and 102 ppm confirmed that endoperoxide bridge of 
dihydroartemisinin was still preserved. The exact assignment for all protons and carbons in 11 
was confirmed based on the HSQC and HMBC spectra. In HSQC spectrum, the correlation of 
carbons 9-CH2- and 9-CH2-CH2- with their protons indicated the signals of protons in 9-CH2- at 
1.11 and 2.22 ppm and in 9-CH2-CH2- at 333 and 444 ppm, respectively. The key cross peaks 
between the protons of 9-CH2- with C-10 and C-13 of murrayafoline A were also found in 
HMBC. The structure of conjugate 11 agreed well with NMR and MS spectra. 
The evaluation of anti-proliferative activity of 3 and 11 was performed with the highest 
concentration of compounds 3 and 11was used for the experiments was 20µg/mL.  The IC50 
values are listed in Table 1. 
Table 1. The cytotoxic activity of 3 and 11. 
No Compounds IC50 (μg/mL)a
Hep-G2b RDb LU-1b FLb 
1 3 > > > > 
2 11 > > > > 
3 Murrayafoline A 6.18 9.04 - 8.91 
4 Ellipticine 0.27 0.32 0.18 0.21 
aIC50 shown for these compounds are the average of three determinations. 
bCell lines: Hep-G2 (liver heptatocellular carcinoma, ATCC-HB-8065), LU (lung adenocarcinoma, 
ACTT-HBT-57), RD (rhabdomyosarcoma, ATCC-CCL-136) and FL (HeLa derivative, human cervix 
carcinoma). 
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The results in Table 1 showed that the conjugates 3 and 11 had no cytotoxicity, while 
murrayafoline A exhibited activity against to three human cancer cell lines including Hep-G2, 
RD and FL with IC50 values of 6.18, 9.04 and 8.91 µg/mL, respectively. The evaluation of 
cytotoxicity of murrayafoline A and its derivatives also revealed that the amine group (NH) at 
9-position could play important role in the cytotoxicity of murrayafoline A. Finally, although 
the conjugates 3 and 11 did not show the activity as expected, but this is a good orientation in 
the design and synthesis of other bioactive derivatives of this carbazole. 
3. CONCLUSSION 
Two new derivatives of murrayafoline A with zerumbone and artemisinin were 
successfully synthesized in good yields and their structures were elucidated by spectroscopic 
methods such as NMR and MS. The cytotoxic activity against the Hep-G2, LU, RD and FL of 
the conjugates was assayed and the structure-antiproliferative activity relationship was also 
discussed. 
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Hai tổ hợp mới 3, 11 của murrayafoline A với zerumbone và artemisinin được chuẩn bị 
bằng phản ứng N-ankyl hóa, trong đó hợp chất 3 được tổng hợp bằng 2 phản ứng N-alkyl hóa 
liên tiếp. Hoạt tính gây độc tệ bào của chúng được đánh giá trên 4 dòng tế bào ung thư Hep-G2, 
LU, RD và Fl. Kết quả chỉ ra rằng cả hai dẫn xuất đã không thể hiện hoạt tính với các dòng tế 
bào được thử nghiệm. 
Từ khóa: murrayafoline A, N-alkyl hóa, hoạt tính gây độc tế bào, sesquiterpen, tổ hợp. 
 
